The Indiana Chronic Disease Management Program

The Milbank Quarterly
Marc B RosenmanThomas S Inui

Abstract

The Indiana Chronic Disease Management Program (ICDMP) is intended to improve the quality and cost-effectiveness of care for Medicaid members with congestive heart failure (chronic heart failure), diabetes, asthma, and other conditions. The ICDMP is being assembled by Indiana Medicaid primarily from state and local resources and has seven components: (1) identification of eligible participants to create regional registries, (2) risk stratification of eligible participants, (3) nurse care management for high-risk participants, (4) telephonic intervention for all participants, (5) an Internet-based information system, (6) quality improvement collaboratives for primary care practices, and (7) program evaluation. The evaluation involves a randomized controlled trial in two inner-city group practices, as well as a statewide observational design. This article describes the ICDMP, highlights challenges, and discusses approaches to its evaluation.

References

Jul 15, 1999·Journal of the American Geriatrics Society·E A ColemanE H Wagner
Jul 16, 1999·International Journal of Medical Informatics·C J McDonaldC Wodniak
Oct 27, 1999·JAMA : the Journal of the American Medical Association·M D CabanaH R Rubin
Jan 4, 2001·American Journal of Preventive Medicine·K M Emmons, S Rollnick
Sep 15, 2001·Journal of General Internal Medicine·K KroenkeJ B Williams
Oct 27, 2001·BMJ : British Medical Journal·N F OlivariusP A Pedersen
Jan 31, 2002·Health Affairs·E H WagnerA Bonomi
Feb 22, 2002·The New England Journal of Medicine·Sara Rosenbaum
Oct 9, 2002·JAMA : the Journal of the American Medical Association·Thomas BodenheimerKevin Grumbach
Oct 17, 2002·JAMA : the Journal of the American Medical Association·Thomas BodenheimerKevin Grumbach
Jan 17, 2003·Health Affairs·Alan Weil
Feb 1, 2003·Annals of Internal Medicine·Arlyss Anderson Rothman, Edward H Wagner
May 23, 2003·The New England Journal of Medicine·John K Iglehart
Jul 10, 2003·JAMA : the Journal of the American Medical Association·Thomas Bodenheimer, Kevin Grumbach
Sep 25, 2003·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Donna Young
Dec 23, 2003·Journal of General Internal Medicine·William M TierneyFredric D Wolinsky
Jan 23, 2004·The New England Journal of Medicine·Arnold M EpsteinMary Beth Hamel
Dec 8, 2004·Health Affairs·Bruce FiremanJoe Selby
Jan 27, 2005·JAMA : the Journal of the American Medical Association·Lawrence P Casalino
Sep 17, 2005·Medical Care·Jingjin LiThomas S Inui

❮ Previous
Next ❯

Citations

Apr 22, 2011·Population Health Management·George RustUsha Sambamoorthi
Nov 21, 2008·Journal of Evaluation in Clinical Practice·Alan J ZillichThomas S Inui
Feb 23, 2008·Health Education & Behavior : the Official Publication of the Society for Public Health Education·Donald E MoriskyJenny B Kotlerman
Mar 30, 2017·Health Services Management Research : an Official Journal of the Association of University Programs in Health Administration·Carmen Huckel SchneiderAndrew Wilson
May 14, 2008·Health Affairs·Ann M HolmesThomas S Inui
Nov 26, 2010·Population Health Management·Ann M HolmesThomas S Inui
Mar 16, 2016·The Cochrane Database of Systematic Reviews·Susan M SmithMartin Fortin
Jan 16, 2021·The Cochrane Database of Systematic Reviews·Susan M SmithMartin Fortin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.